Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild ‐to‐moderate renal impairment

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - August 30, 2018 Category: Endocrinology Authors: F. Javier Escalada MD , Serge Halimi MD , Peter A. Senior PhD , Mireille Bonnemaire MD , Anna M. G. Cali MD , Lydie Melas ‐Melt MSc , Janaka Karalliedde PhD , Robert A. Ritzel MD Source Type: research